Gabapentin enacarbil clinical trials
Also written XP13512, GSK1838262, Horizant and HORIZANT 300 mg.
How each study uses gabapentin enacarbil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the gabapentin enacarbil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 6 Apr 2011 · HORIZANT · NDA 022399 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
31 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 6
XenoPort, Inc. (17) · Astellas Pharma Inc (7) · Arbor Pharmaceuticals, Inc. (1) · The Cleveland Clinic (1) · University of Missouri-Columbia (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · University of Texas at Austin (1) · Theresa Zesiewicz, MD (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A prodrug of Gabapentin source
Studies
Open first, then newest update. How each study uses gabapentin enacarbil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 31
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseaseRecruitingPhase 4University of Texas at AustinNCT03082755Written as Gabapentin EnacarbilHow we know
- A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedPhase 4Astellas Pharma IncNCT03053427Written as Gabapentin enacarbilHow we know
- Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal ImpairmentCompletedPhase 4Astellas Pharma IncNCT01981941Written as Gabapentin enacarbilHow we know
- An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug UsersCompletedPhase 4Arbor Pharmaceuticals, Inc.NCT06097676Written as Gabapentin Enacarbil Immediate Release (GE-IR) 200 mgHow we know
- Effect of Gabapentin Enacarbil on Opioid Consumption and Pain ScoresCompletedNot applicableThe Cleveland ClinicNCT02840240Written as Gabapentin enacarbilHow we know
- The Effect of Horizant (Gabapentin Enacarbil) on AugmentationCompletedNot applicableUniversity of Missouri-ColumbiaNCT02642315Written as HorizantHow we know
- Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg SyndromeTerminatedPhase 4Theresa Zesiewicz, MDNCT02117076Written as Gabapentin enacarbil extended releaseHow we know
- An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownPhase 4XenoPort, Inc.NCT02560766Written as HORIZANT 300 mgHow we know
- An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownPhase 4XenoPort, Inc.NCT02633683Written as HORIZANT 600 mgHow we know
- Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment StudyCompletedPhase 4XenoPort, Inc.NCT01668667Written as GSK1838262 600 mgHow we know
- A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLSWithdrawnPhase 1XenoPort, Inc.NCT02633657Written as HORIZANT 300 mgHow we know
- HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use DisorderCompletedPhase 2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT02252536Written as gabapentin enacarbilHow we know
- ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and HaemodialysisCompletedPhase 1Astellas Pharma IncNCT02629224Written as ASP8825How we know
- Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedPhase 3Astellas Pharma IncNCT02658188Written as ASP8825How we know
- ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825CompletedPhase 1Astellas Pharma IncNCT02632331Written as ASP8825How we know
- Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs SyndromeStatus unknownPhase 4Cleveland Sleep Research CenterNCT02424695Written as Gabapentin Enacarbil (GEn)How we know
- ASP8825 - Study in Patients With Restless Legs SyndromeCompletedPhase 2Astellas Pharma IncNCT00530530Written as ASP8825How we know
- Simulated Driving Study in Restless Legs SyndromeCompletedPhase 2XenoPort, Inc.NCT01332318Written as XP13512How we know
- A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)CompletedPhase 2XenoPort, Inc.NCT00619476Written as GEn 1200mg/dayHow we know
- A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)CompletedPhase 2XenoPort, Inc.NCT00643760Written as GEn 1200mg/dayHow we know
Codes
What other systems call gabapentin enacarbil · ClinicalTrials.gg INT004712
- UNII (FDA) 75OCL1SPBQGABAPENTIN ENACARBILConfirmed FDA, Wikidata
- RxNorm 1101333Confirmed FDA, Wikidata
- Wikidata Q5515257gabapentin enacarbilConfirmed FDA, Wikidata
- NCI Thesaurus C79579Gabapentin EnacarbilOne source FDA
- DrugBank DB08872One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 75OCL1SPBQ | GABAPENTIN ENACARBIL | Confirmed FDA, Wikidata |
| RxNorm | 1101333 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5515257 | gabapentin enacarbil | Confirmed FDA, Wikidata |
| NCI Thesaurus | C79579 | Gabapentin Enacarbil | One source FDA |
| DrugBank | DB08872 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.